<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02683382</url>
  </required_header>
  <id_info>
    <org_study_id>SDE</org_study_id>
    <nct_id>NCT02683382</nct_id>
  </id_info>
  <brief_title>Effects of a Moisturizing Product on Dry Eye and Skin</brief_title>
  <acronym>SDE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Petra Larmo</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Turun Silmäexpertit Oy, Turku, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tekes - The Finnish Funding Agency for Technology and Innovation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Finnsusp Oy, Lieto, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aromtech Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dry eye is a common syndrome associated with symptoms of dryness, burning, itching and
      grittiness of eyes. The objective of this study is to investigate the effects of a
      moisturizing product in liquid formula on symptoms and signs of dry eye and on skin around
      the eyes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in symptoms of dry eye: Ocular Surface Disease Index (OSDI), scores of dryness, burning and foreign body sensation of eyes</measure>
    <time_frame>Part 1: baseline, 2, 4, and 6 hours. Part 2: baseline, 1 day, 3 and 9 days. Part 3: baseline and 45 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in tear film osmolarity (mOsm/L)</measure>
    <time_frame>Part 1: baseline, 2, 4, and 6 hours. Part 2: baseline, 1 day, 3 and 9 days. Part 3: baseline and 45 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in tear film break-up time (s)</measure>
    <time_frame>Part 1: baseline, 2, 4, and 6 hours. Part 2: baseline, 1 day, 3 and 9 days. Part 3: baseline and 45 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in tear secretion, Schirmer test (mm/min)</measure>
    <time_frame>Part 1: baseline, 2, 4, and 6 hours. Part 2: baseline, 1 day, 3 and 9 days. Part 3: baseline and 45 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in signs of irritation of eyes, scoring by an eye specialist</measure>
    <time_frame>Part 1: baseline, 2, 4, and 6 hours. Part 2: baseline, 1 day, 3 and 9 days. Part 3: baseline and 45 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in transepidermal water loss from skin around the eyes (g/m2h)</measure>
    <time_frame>Part 1: baseline, 2, 4, and 6 hours. Part 2: baseline, 1 day, 3 and 9 days. Part 3: baseline and 45 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in other symptoms of dry eye: soreness, grittiness, watery eyes, redness, blurring of eyes (daily symptom logbooks: scoring in scale from 0 to 3)</measure>
    <time_frame>Part 2: change from baseline to 9 days; Part 3: change from baseline to 45 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Dry Eye Syndromes</condition>
  <arm_group>
    <arm_group_label>Moisturizing Eye Product (product in development)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Moisturizing eye product in liquid form (medical device product in development). Part 1 of the study: Administered to both eyes 4 times/day for 1 day. Part 2: to one eye 4 times/day for 9 days. Part 3: to one eye 4 times/day for 45 days. Parts 2 &amp; 3: treatment eyes randomized.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moisturizing Eye Product, Comparison</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Moisturizing eye product in liquid form (medical device CE-marked). Part 2 of the study: Administered to one eye 4 times/day for 9 days. Treatment eyes randomized.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Part 3 of the study: other eye is a control eye with no treatment for 45 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Moisturizing Eye Product in Liquid Formula</intervention_name>
    <description>Moisturizing Eye Product in Liquid Formula for dry eyes and skin around the eyes</description>
    <arm_group_label>Moisturizing Eye Product (product in development)</arm_group_label>
    <arm_group_label>Moisturizing Eye Product, Comparison</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dry eye symptoms OSDI score 20 or higher

          -  Dryness, burning or foreign body sensation moderate or higher

        Exclusion Criteria:

          -  Severe eye diseases

          -  Known allergy to any of the ingredients of the product

          -  Laser surgery of eyes during the last year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Minna Sandberg-Lall, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turun Silmäexpertit Oy, Turku, Finland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Turun Silmäexpertit Oy</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2016</study_first_submitted>
  <study_first_submitted_qc>February 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2016</study_first_posted>
  <last_update_submitted>October 11, 2016</last_update_submitted>
  <last_update_submitted_qc>October 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Aromtech Ltd.</investigator_affiliation>
    <investigator_full_name>Petra Larmo</investigator_full_name>
    <investigator_title>Ph.D., R&amp;D Manager</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

